Growth inhibition of experimental liver metastasis by portal embolization

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1515-1521

  Iuchi, Masahiro ^a   Ishikawa, Masashi ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

AH130; Liver metastasis; Portal embolization

Indexed keywords

DYE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BODY WEIGHT; CANCER INHIBITION; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HEPATIC ARTERY LIGATION; HEPATOMA CELL; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER BLOOD FLOW; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER RESECTION; LIVER WEIGHT; MALE; NONHUMAN; PORTAL EMBOLIZATION; PORTAL VEIN; PRIORITY JOURNAL; RAT; STAINING; SURVIVAL TIME; VEIN LIGATION;

ANIMALS; ATROPHY; EMBOLIZATION, THERAPEUTIC; HYPERTROPHY; LIVER NEOPLASMS; LIVER REGENERATION; MALE; PORTAL VEIN; RATS;

EID: 79952427099     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nagasue N, Akamizu H, Yukawa H, Yunk I: Hepato-cellular psudotumor in the cirrhotic liver. Cancer 1984; 54:2187-2194.
2. Liver cancer study group of Japan: Primary liver cancer in Japan. Clinocopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.
3. Takada T, Yasuda H, Uchiyama K, Hasegawa H, Shikata J: Contrast-enhanced intraoperative ultrasonography of small hepatocellular carcinomas. Surgery 1990; 107:528-532. (Pubitemid 20156654)
4. Nagasue N, Ito K, Ogawa Y, Sasaki Y, Hirose S, Yukaya H, Aratani K: Routine angiography following partial hepatectomy in patients with malignant lesion of the liver. Surg Gynecol Obstet 1982; 155:697-704.
5. Kanematsu T, Matsumata T, Takenaka K, Yoshida Y, Higashi H, Sugimachi K: Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg 1988; 75:203-206.
6. Nakamura H, Tanaka T, Hori S, Yoshida H, Kuroda C, Okamura C, Sakurai M: Transcatheter embolization of hepatocellular carcinoma; Assessments of efficacy in cases of resection following embolization. Radiology 1983; 147:401-405.
7. Livraghi T, Festi D, Monti F, Salmi A, Vettori C: US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161:309-312. (Pubitemid 17173275)
8. Rous P, Laimore LD: Relation of the portal blood to liver maintenance; a demonstration of liver atrophy conditional on compensation. J Exp Med 1920; 31:609-632.
9. Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O. Ishikawa T: Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg 1975; 130:296-302.
10. Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H: Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J Jpn Soc Clin Surg 1984; 45:1558-1564.
11. Kinoshita H, Sasaki K, Hirohashi K, Igawa S, Yamasaki O, Kubo S: Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10:803-808. (Pubitemid 17197533)
12. Shimamura T, Nakajima Y, Une T, Namieno T, Uchino J: Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: A clinical study. Surg 1997; 121:135-141. (Pubitemid 27091767)
13. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R: Extension of surgical indication for hepatocellular carcinoma by portal vein embolization. World J Surg 1993; 17:109-115. (Pubitemid 23189031)
14. Uesaka K, Nimura Y, Nagino M: Changes in hepatic lobar function after right portal vein embolization. Ann Surg 1996; 223:77-83.
15. Kraus GE, Beltran A: Effect of induced infarction on rat liver implanted with Walker carcinoma 256. Arch Surg 1959; 79:769-774.
16. Hirono T: Effect of segmental interruption of portal venous blood supply on implanted tumor in the liver of rats. Arch Jpn Chir 1964; 33:526-559.
17. Yoshihiro I: Effects of portal ligation to the experimental liver tumor in rabbits. Nagasaki Igaku-kai Zassi 1976; 50:254-265. (in Japanese)
18. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527. (Pubitemid 20156653)
19. Nagino M, Nimura Y, Kamiya J: Right or left trisegment portal vein embolization before hepatic trisegmentectomy for bile duct carcinoma. Surgery 1995; 117:677-681.
20. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, Moriya Y: Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994; 115:674-677. (Pubitemid 24189760)
21. Mizutani J, Hiraoka T, Yamashita R, Miyauchi Y: Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 1992; 65:794-797.
22. Abe Y, Asano T, Isono K: The effect of the free radicals from non parenchymal cells of the liver on the development of liver metastases in rat. J Jpn Surg Soc 1993; 94:1092-1099.
23. Lien WM, Ackerman NB: The blood supply of experimental liver metastasis. II. A microcirculatory study of the normal and tumor vessel of the liver with the use of perfused silicone rubber. Surgery 1970; 68:334-340.
24. Ishikawa M, Yogita S, Iuchi M, Tashiro S: Experimental and clinical studies on liver regeneration following transcatheter portal embolization. Hepato-Gastroenterology. 2000; 47:226-233. (Pubitemid 30085417)
25. Richardson PDI, Withrington PG: Liver blood flow. Gastroenterology 1981; 81:159-173.
26. Elias D, de Baere T, Roche A, Ducreux M, Leclere J, Lasser P: During liver regeneration following right portal embolization the growth rate of liver metastasis is more rapid than that of the liver parenchyma. Br J Surg 1999;81:159-173.
27. Zhang W, Arii S, Sasaoka T, Adachi Y, Funaki N, Higashitsuji H, Fujita S, Furutani M, Mise M, Ishiguro S, Kitao T, Tobe T, Naito M: The role of Kupper cells in the surveillance of tumor growth in the liver. J Surg Res 1993; 55:140-146.
28. Bure AW, Hillan KJ, Mclaughlin KE, Ferrier R, Chapman D, Mathew J, Burt AD: Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology 1996; 24:1282-1287. (Pubitemid 26365939)
29. Brunda MJ, Listro L, Warrier RR, Wright RB, Hubbard RB, Murphy M, Wolf SF, Gately MK: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993; 178:1223-1230. (Pubitemid 23277355)
30. Ackerman NB, Lien WM, Silverman NA: The blood supply of experimental liver metastasis. III. The effects of acute ligation of the hepatic artery or portal vein. Surgery 1972; 71:636-641.